Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia, Moderate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00088673
What this trial is testing

Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Bellus Health Inc. - a GSK company 950
Not applicableUnknownNCT01958983
What this trial is testing

Music Therapy to Promote Emotion and Cognition for Dementia

Who this might be right for
Dementia
Chang Gung Memorial Hospital 30
Not applicableLooking for participantsNCT04957537
What this trial is testing

Semantic Rehabilitation for Patients With Primary Progressive Semantic Aphasia

Who this might be right for
Primary Progressive Aphasia
University Hospital, Toulouse 15
Not applicableUnknownNCT04555629
What this trial is testing

Advanced Cognitive Stimulation Therapy Hong Kong (ACST-HK)

Who this might be right for
DementiaDementia, VascularDementia, Mixed+5 more
University College, London 32
Post-approval studies (Phase 4)UnknownNCT05430867
What this trial is testing

Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
TreatmentEfficacySafety+1 more
First Affiliated Hospital Xi'an Jiaotong University 150
Testing effectiveness (Phase 2)Study completedNCT00959192
What this trial is testing

Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 32
Post-approval studies (Phase 4)Looking for participantsNCT05908695
What this trial is testing

An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. 1,312
Large-scale testing (Phase 3)Study completedNCT00097916
What this trial is testing

An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Forest Laboratories 34
Testing effectiveness (Phase 2)Study completedNCT01527916
What this trial is testing

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 438
Testing effectiveness (Phase 2)UnknownNCT02833792
What this trial is testing

Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease

Who this might be right for
Alzheimer Dementia
Stemedica Cell Technologies, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT04070378
What this trial is testing

Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Marc L Gordon, MD 16
Not applicableStudy completedNCT01081743
What this trial is testing

Effectiveness of Care Management in Alzheimer Patients

Who this might be right for
Alzheimer Disease or Associated DisorderMild to Moderately Severe Dementia
Institut de Sante Publique, d'Epidemiologie et de Developpement 270
Large-scale testing (Phase 3)Study completedNCT04669028
What this trial is testing

NE3107 in Probable Alzheimer's Disease

Who this might be right for
Alzheimer Disease
BioVie Inc. 439
Testing effectiveness (Phase 2)Study completedNCT00812565
What this trial is testing

Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Octapharma 58
Testing effectiveness (Phase 2)Study completedNCT00568776
What this trial is testing

ELND005 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
OPKO Health, Inc. 353
Large-scale testing (Phase 3)Looking for participantsNCT06976203
What this trial is testing

Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 586
Large-scale testing (Phase 3)Study completedNCT00623103
What this trial is testing

Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)

Who this might be right for
Parkinson's Disease Dementia
Novartis 583
Large-scale testing (Phase 3)Study completedNCT00818662
What this trial is testing

Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease

Who this might be right for
Alzheimer´s Disease
Baxalta now part of Shire 390
Large-scale testing (Phase 3)Ended earlyNCT01739348
What this trial is testing

An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 2,211
Testing effectiveness (Phase 2)UnknownNCT01255046
What this trial is testing

Study of STA-1 as an Add-on Treatment to Donepezil

Who this might be right for
Alzheimer Disease
Sinphar Pharmaceutical Co., Ltd 136
Next Page